Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Afshari P, Myles-Worsley M, Cohen OS, Tiobech J, Faraone SV, Byerley W, Middleton FA.

Mol Neuropsychiatry. 2015 Oct;1(3):125-44. doi: 10.1159/000433599. Epub 2015 Jul 8.

2.

Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.

O'Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.

Transl Psychiatry. 2015 Jun 9;5:e579. doi: 10.1038/tp.2015.74.

3.

Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.

Kaur H, Jajodia A, Grover S, Baghel R, Jain S, Kukreti R.

Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):635-46. doi: 10.1002/ajmg.b.32268. Epub 2014 Sep 11.

PMID:
25209194
4.

Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia.

Spangaro M, Bosia M, Zanoletti A, Bechi M, Mariachiara B, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R.

Pharmacogenomics. 2014 May;15(7):925-32. doi: 10.2217/pgs.14.42.

PMID:
24956246
5.

[Role of glutamate transporters in the pathophysiology of major mental illnesses].

Tanaka K.

Nihon Yakurigaku Zasshi. 2013 Dec;142(6):291-6. Review. Japanese. No abstract available.

PMID:
24334928
6.

Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness.

Feresten AH, Barakauskas V, Ypsilanti A, Barr AM, Beasley CL.

Schizophr Res. 2013 Oct;150(1):252-7. doi: 10.1016/j.schres.2013.07.024. Epub 2013 Aug 1.

PMID:
23911257
7.

Overstimulation of NMDA receptors impairs early brain development in vivo.

Aida T, Ito Y, Takahashi YK, Tanaka K.

PLoS One. 2012;7(5):e36853. doi: 10.1371/journal.pone.0036853. Epub 2012 May 11.

8.

Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment.

Wilmsdorff MV, Blaich C, Zink M, Treutlein J, Bauer M, Schulze T, Schneider-Axmann T, Gruber O, Rietschel M, Schmitt A, Falkai P.

World J Biol Psychiatry. 2013 Sep;14(7):490-9. doi: 10.3109/15622975.2011.645877. Epub 2012 Mar 16.

PMID:
22424243
9.

Prenatal exposure to PCP produces behavioral deficits accompanied by the overexpression of GLAST in the prefrontal cortex of postpubertal mice.

Lu L, Mamiya T, Lu P, Toriumi K, Mouri A, Hiramatsu M, Zou LB, Nabeshima T.

Behav Brain Res. 2011 Jun 20;220(1):132-9. doi: 10.1016/j.bbr.2011.01.035. Epub 2011 Jan 26.

PMID:
21277907
10.

Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocol.

Pickering C, Chau PP, Söderpalm B, Ericson M.

Front Behav Neurosci. 2010 Jun 10;4:32. doi: 10.3389/fnbeh.2010.00032. eCollection 2010.

11.

Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.

Bauer D, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.

Schizophr Res. 2010 Mar;117(1):92-8. doi: 10.1016/j.schres.2009.07.025. Epub 2009 Aug 27.

12.

Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.

Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, Holmes A.

Neuropsychopharmacology. 2009 May;34(6):1578-89. doi: 10.1038/npp.2008.215. Epub 2008 Dec 10.

13.

Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.

Lyon L, Kew JN, Corti C, Harrison PJ, Burnet PW.

Synapse. 2008 Nov;62(11):842-50. doi: 10.1002/syn.20553.

14.
15.

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J.

Science. 2008 Apr 25;320(5875):539-43. doi: 10.1126/science.1155174. Epub 2008 Mar 27.

16.

Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia.

Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, Ninomiya H, Iwata N, Ozaki N, Fukumaki Y.

Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):271-8.

PMID:
17221839
17.

Autoradiography of [3H]aspartate and glutamate transport in schizophrenia.

Balcar VJ, Nanitsos EK.

Neuropsychopharmacology. 2006 Mar;31(3):685-6; author reply 687-8. No abstract available.

18.

Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.

Lauriat TL, Dracheva S, Chin B, Schmeidler J, McInnes LA, Haroutunian V.

Neuroscience. 2006 Feb;137(3):843-51. Epub 2005 Nov 16.

PMID:
16297566
19.

Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures.

Vallejo-Illarramendi A, Torres-Ramos M, Melone M, Conti F, Matute C.

Glia. 2005 May;50(3):276-9.

PMID:
15739191
20.

Supplemental Content

Loading ...
Support Center